Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT03908931
Recruiting Not applicable

Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results

NCT03908931 · tracked via the Priya Life Science France tracker
Sponsor
Versailles Hospital
Phase
Not applicable
Started
2019-04-01
Last updated
2026-03-17

Condition(s) studied

Osteochondral Defect

Investigational drug(s) / intervention(s)

MRI

MRI: Follow up of osteochondral surgery by MRI and clinical examination

Study summary

The purpose of this study is to evaluate the clinical results and MRI imaging of autologous cartilage reconstructions or collagen matrix of the knee.

There is currently little data in the literature on clinical outcomes and imaging of this type of lesion.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * cartilaginous reconstruction by autologous transplant or collagenous chondro-inducing knee matrix * \> 18 years Exclusion Criteria: * Other cartilaginous reconstruction techniques, * other than knee joint

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CH de Versailles Le Chesnay France Recruiting

More Versailles Hospital trials in France

COPD-ICU Multicentre Prospective Observational Register Recruiting
Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction Starting soon
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm Recruiting
Descriptive Study of Multiligamentary Reconstruction of the Knee Recruiting
EWALL-PH OBSERVARTORY 2022 Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03908931 on ClinicalTrials.gov ↗ ← All trials in France